Generics

We manufacture and market the most expansive portfolio of generic products in the Baltics. Teva continues to pursue a rich future in generics as we focus on patient needs, improving compliance, convenience, efficacy and safety, and providing affordable generic products to Baltic patients and society. Every year we launch tens of new generic products.

Teva Generics worldwide

A global leader in generic pharmaceuticals ◦ US generics market leader, with approximately 20% market share ◦ 850 molecules – the broadest generic portfolio in the industry ◦ 73 billion tablets and capsules, and over 720 million sterile units manufactured in 2012 ◦ 75 pharmaceutical and API production facilities around the world ◦ Over 1.5 million Teva prescriptions are written each day in the US ◦ 1 out of every 6 generic prescriptions in the US is filled with Teva products ◦ 2.7M Teva prescriptions are written in the EU each day ◦ 1,103 generic approvals in Europe, as of December 2012 ◦ Approximately 2,131 marketing authorisation applications pending approval in 30 European countries

Generic facts in Baltics

A top 3 company in generic pharmaceuticals in the Baltics by value and volume (SoftDent and Estonian State Agency of Medicines data 2013) ◦ 120 molecules ◦ One of the broadest generic portfolios in the Baltics - 120 molecules in major therapeutic areas: cardiovascular, oncology, psychiatry, neurology, gastroenterology, anti-infectives and anti-inflammatory, urology, endocrinology and many more ◦ In the conditions of a significant lack of Health Care funding in the Baltic Region, our generic medicines deliver an affordable treatment option for each and every patient
 

 Generic Q&A

 

Why is Teva a global leader in generic pharmaceuticals?

Since it was founded in 1901, and for over a century, Teva Pharmaceutical Industries Ltd. has been pursuing the same goal: to make high-quality products accessible to more people and more patients around the world. The scale of our operations, our exceptional know-how and our in-depth understanding of the pharmaceutical business made us the world's leading generic pharmaceutical company. Teva brings you the latest drug developments, introduces the most advanced dosage forms, meets the highest quality standards, and offers the most competitive prices.

1/9

Are generic drugs safe?

A generic drug is a bioequivalent to the original innovative drug and meets the same quality standards. The active ingredient, the content, the dosage form and the usage of a generic drug are similar to those of an innovative drug. Generic drugs are essentially the same as the original drug, but are offered at a lower price.

2/9

What does Bioequivalence mean?

Bioequivalence demonstrates a similar profile of behaviour of two products in the human body, in terms of the rate and extent of absorption of the active pharmaceutical ingredient from the gastrointestinal (GI) tract to the blood stream. Bioequivalence study is a regulatory requirement and is performed for all generic drugs to ensure their efficacy and safety.

3/9

How can you make sure that the generic drug is safe, having tried it on only a limited number of patients?

The generic product's active pharmaceutical ingredient (API) is identical to that of the innovative drug, its purity profile is similar and it is found to be bioequivalent; therefore its safety and efficacy are also comparable.

4/9

Why are generic drugs cheaper?

Generic companies are not required to perform lengthy and costly toxicological and clinical studies; therefore, they can offer their products to the public at considerably lower costs.

5/9

Does every drug have a generic equivalent?

As long as a drug is protected by patents, a generic alternative can't be launched. Sometimes a generic version is approved and available in a specific country or countries, while unavailable in others. However, with the growing emphasis on generics, multiple generic versions of an innovative drug are often developed around about the time it becomes "off patent". Nonetheless, in some instances, even after a patent has expired there is no generic alternative. This may happen due to cost considerations, in cases of drugs designed for a limited use or requiring complex manufacturing processes.

6/9

Does the generic drug look the same as its original equivalent?

Sometimes the generic version of a drug may have a different colour or shape from its innovative original, but these changes do not affect the drug's attributes.

7/9

Why are generic drugs’ names different from the original drugs' names?

Regulators demand that generic drugs be given a different name from the original drugs, in order to avoid confusion. Typically, the generic name of a drug is based on the name of its API, whereas the names given to original drugs are intended for marketing purposes.

8/9

What are generic drugs?

Generic drugs offer a therapeutic alternative to innovative drugs. They contain the same active ingredients as the original innovative products, and are available in the same strengths and dosage forms as the original.

9/9